Japan’s pharmaceutical giant Takeda seeks expansion in Asia

SINGAPORE: Health spending in emerging markets is expected to generate 70 per cent of of global pharmaceutical growth by 2016. And Japan’s Takeda Pharmaceutical Company is banking on its research and development activities to tap into that.

Share